Northstar Group, Inc. Abb Vie Inc. Transaction History

Northstar Group, Inc.

$613 Million
Q1 2025

A detailed history of Northstar Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Northstar Group, Inc. holds 8,512 shares of ABBV stock, worth $1.55 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares

8,512

Previous 8,454 0.69%

Holding current value

$1.55 Million

Previous $1.5 Million 18.71%

% of portfolio

0.29%

Previous 0.25%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$169.2 - $216.66 $9,813 - $12,566	58 Added 0.69%	8,512 $1.78 Million
Q4 2024 Jan 28, 2025	SELL	$164.99 - $203.87 $5,114 - $6,319	-31 Reduced 0.37%	8,454 $1.5 Million
Q3 2024 Oct 08, 2024	SELL	$163.84 - $199.33 $16,384 - $19,933	-100 Reduced 1.16%	8,485 $1.68 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $9,632 - $10,847	-70 Reduced 0.81%	8,585 $1.33 Million
Q3 2023 Oct 19, 2023	SELL	$133.59 - $154.65 $15,763 - $18,248	-118 Reduced 1.35%	8,655 $1.29 Million
Q2 2023 Aug 02, 2023	BUY	$132.51 - $164.9 $13,251 - $16,490	100 Added 1.15%	8,773 $1.18 Million
Q4 2022 Jan 25, 2023	SELL	$138.31 - $165.87 $24,204 - $29,027	-175 Reduced 1.98%	8,673 $0
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $29,175 - $37,091	-212 Reduced 2.34%	8,848 $1.36 Million
Q1 2022 May 05, 2022	SELL	$131.98 - $163.75 $11,350 - $14,082	-86 Reduced 0.94%	9,060 $1.47 Million
Q4 2021 Jan 31, 2022	SELL	$107.43 - $135.93 $3,008 - $3,806	-28 Reduced 0.31%	9,146 $1.24 Million
Q3 2021 Nov 02, 2021	SELL	$106.4 - $120.78 $6,916 - $7,850	-65 Reduced 0.7%	9,174 $989,000
Q2 2021 Jul 28, 2021	BUY	$105.21 - $117.21 $8,942 - $9,962	85 Added 0.93%	9,239 $1.04 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $4,194 - $4,617	41 Added 0.45%	9,154 $991,000
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $724 - $978	9 Added 0.1%	9,113 $976,000
Q3 2020 Nov 12, 2020	BUY	$85.91 - $100.83 $859 - $1,008	10 Added 0.11%	9,104 $797,000
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $5,429 - $7,265	-74 Reduced 0.81%	9,094 $893,000
Q1 2020 May 04, 2020	BUY	$64.5 - $97.79 $580 - $880	9 Added 0.1%	9,168 $698,000
Q4 2019 Jan 21, 2020	BUY	$72.13 - $90.25 $721 - $902	10 Added 0.11%	9,159 $811,000
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $10,895 - $13,099	-173 Reduced 1.86%	9,149 $693,000
Q2 2019 Jul 12, 2019	BUY	$65.7 - $83.98 $591 - $755	9 Added 0.1%	9,322 $678,000
Q1 2019 Apr 16, 2019	SELL	$77.14 - $90.79 $30,084 - $35,408	-390 Reduced 4.02%	9,313 $750,000
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $16,192 - $19,970	-208 Reduced 2.1%	9,703 $895,000
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $8,268 - $9,192	-93 Reduced 0.93%	9,911 $937,000
Q2 2018 Jul 27, 2018	BUY	$89.78 - $106.23 $538 - $637	6 Added 0.06%	10,004 $927,000
Q1 2018 Apr 13, 2018	SELL	$92.01 - $123.21 $16,837 - $22,547	-183 Reduced 1.8%	9,998 $946,000
Q4 2017 Jan 23, 2018	BUY	$89.56 - $98.21 $26,151 - $28,677	292 Added 2.95%	10,181 $985,000
Q3 2017 Oct 16, 2017	BUY	$69.85 - $89.22 $690,746 - $882,296	9,889	9,889 $879,000

Others Institutions Holding ABBV

# of Institutions

4,259

Shares Held

1.27B

Call Options Held

18.2M

Put Options Held

15.5M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $321B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northstar Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northstar Group, Inc. with notifications on news.

Account

Northstar Group, Inc. Abb Vie Inc. Transaction History